In this BoardsCast episode, we finish Tobias Chapter 97 — Pancreas by confronting the most common long-game trap after pancreatitis:

Surviving the fire doesn’t mean the factory works.

This episode reframes pancreatic “recovery” the way the boards want you to think about it: acute survival often creates a new baseline — and the consequences show up weeks to months later as endocrine failure (diabetes), exocrine failure (EPI), or progressive decline from chronic fibrosis. 

You’ll learn:

• Why acute resolution ≠ functional recovery (the pancreas doesn’t “reset”) 
• The two assembly lines: exocrine (≈98% of mass) vs endocrine islets — and why severe necrosis can destroy both 
• Post-pancreatitis diabetes: beta-cell loss → insulin deficiency → PUPD + weight loss (not autoimmune Type 1) 
• Post-pancreatitis EPI: acinar destruction → loss of pancreatic lipase → steatorrhea + ravenous appetite with weight loss 
• Chronic pancreatitis mechanics: stellate cells → collagen deposition → fibrosis → shrinking, nodular “concrete pancreas” 
• The predictable clinical misses: assuming “better” means healed, ignoring subtle PU/PD, missing slow weight loss, brushing off greasy stool 

Key takeaway: the acute crisis ends — the long-term deficit begins.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we continue Tobias Chapter 97 — Pancreas with the scenario that forces a full paradigm shift on the table:

It looked like a gallbladder case until the pancreas lit up. 

This episode teaches the dominant mental model for the biliary–pancreatic intersection:

The pancreas and biliary system don’t just live next to each other — they share plumbing. And in physiology, shared plumbing means shared consequences.

The core rule you’ll remember from this entire episode: obstruction converts flow into pressure.

From there, everything makes sense:

• How a blocked major duodenal papilla drives ductal pressure, enzyme stasis, and premature activation (hydraulic crisis before inflammatory crisis) 
• Why cats are higher-risk anatomically (single duct fusion with the common bile duct in most cats) 
• The “two-way trap”: biliary obstruction can trigger pancreatitis, and pancreatitis can compress the bile duct and create obstruction 
• The clinical decision hierarchy when both systems are involved: stabilize shock first, then relieve pressure / restore flow, and minimize pancreatic handling
• The board-level synthesis answer: vomiting + abdominal pain + hyperbilirubinemia + bile duct dilation = shared outflow obstruction with secondary pancreatic involvement 

Bottom line: when this intersection clogs, you’re not managing “two diseases.”
 You’re managing one interconnected crisis — and obstruction changes everything.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we continue Tobias Chapter 97 — Pancreas by reframing pancreatic surgery with the only rule that matters:

It is not an anatomical decision. It is a timing decision.

This episode builds a judgment-focused, physiology-driven framework for the key binary the boards want you to separate instantly:

Sterile necrosis vs infected necrosis.

Because early in pancreatitis, CT and ultrasound can look terrifying — and still be sterile. Operating in that early edematous phase doesn’t “fix the pancreas.” It often makes it worse by triggering hemorrhage, spreading activated enzymes, and amplifying SIRS into multi-organ failure. 

You’ll learn:

• The governing rule: timing determines survival — not technical aggression
• The clinical binary: sterile necrosis = medical management vs infected necrosis/abscess = source control
• Why imaging is a trap early: sterile and septic necrosis can look identical on CT/US 
• Why early surgery backfires: friable tissue + no demarcation → hemorrhage, enzyme spread, iatrogenic SIRS spike 
• The true pivot point: confirmed infection + systemic deterioration (persistent fever, worsening leukogram, refractory hypotension, organized collections) 
• What “surgery” should mean here: drainage and restraint (JP/sump drain, limited debridement) — not aggressive necrosectomy 
• The board answer: when infection is proven, drain the abscess while minimizing trauma — because the pancreas can regenerate once the septic burden is removed 

Key takeaway: cut too early and you amplify the fire. wait too long and sepsis kills the patient.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we continue Tobias Chapter 97 — Pancreas by forcing the single most important reframe in acute pancreatitis:

This is not an abdominal problem. It’s a circulatory collapse problem.

Acute pancreatitis starts as a local enzyme injury — and then it flips into a systemic disease when containment fails. Once cytokines and inflammatory mediators escape, the patient crosses the only line that matters:

local fire → systemic explosion.

You’ll learn:

• The dominant mental model: local enzyme injury triggers systemic vascular collapse
• Why the pancreas self-destructs: premature trypsin activation triggers a cascade of autodigestion 
• The true turning point: containment breach → cytokines enter circulation → SIRS
• Why these patients “have fluid” but are dying of shock: capillary leak + third spacing into the abdomen/retroperitoneum 
• The dual shock state: distributive shock (vasodilation) + hypovolemic shock (third spacing) 
• The systemic endpoints that actually kill: AKI (pre-renal), ARDS, DIC
• The 5 predictable clinical errors: under-resuscitating, treating pain without perfusion, delaying hemodynamic support, operating too early, ignoring coagulation 

Key takeaway: pancreatitis doesn’t kill because it hurts — it kills because it spreads.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we begin Tobias Chapter 97 — Pancreas by deleting the most misleading word in small animal medicine: “pancreatitis.”

Because the pancreas doesn’t “inflame.” It digests.

This episode rebuilds the mental model: the pancreas is a controlled chemical plant that produces enzymes designed to destroy proteins and fat — and the only thing preventing catastrophe is containment. When containment fails, the organ doesn’t just injure itself. It injures everything around it and can trigger a systemic shutdown. 

You’ll learn:

• Why autodigestion is the default failure mode (premature activation of zymogens) 
• The 3 safety systems that normally prevent self-destruction: inactive zymogens, membrane-bound granules, and pancreatic secretory trypsin inhibitor
• What each enzyme does when the weapon misfires: trypsin starts the cascade, lipase causes fat necrosis/saponification, elastase damages vessels → hemorrhage + thrombosis
• Why severe pancreatitis kills systemically: enzyme spill → cytokine storm → SIRS with vascular leak/third spacing → hypovolemia → DIC/AKI/ARDS
• The predictable clinical traps: treating it like gastroenteritis, underestimating “invisible” fluid loss, operating too early, and ignoring systemic monitoring
• The anatomy pearl: pancreatic head inflammation can compress the bile duct → extrahepatic biliary obstruction
• The surgical doctrine: pancreatitis is medical first — surgery is reserved for abscess, infected necrosis/sepsis, or obstructive complications

Key takeaway: don’t treat vomiting — treat a containment failure that can take down the whole body.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we finish Tobias Chapter 96 — Hepatic Vascular Anomalies with the nightmare every shunt surgeon fears:

The shunt was fixed… and the problems weren’t.

This episode explains why shunt attenuation is not a “cure switch.” It’s a forced physiologic reset — and the complications that follow (especially PANS and portal hypertension) are usually adaptation problems, not surgical mistakes. 

You’ll learn:

• Why attenuation is a pressure + adaptation event, not a simple plumbing repair 
• What the liver looks like pre-op: underperfused, hypoplastic, low resistance — and why redirecting flow can spike sinusoidal pressure 
• Why the danger zone exists: surgery takes an hour, hepatic hypertrophy takes weeks to months
• PANS (post-attenuation neurologic signs): why seizures/blindness/agitation peak at 48–80 hours and how to treat it (CRIs like propofol; Keppra) 
• Portal hypertension warning signs, plus the intra-op pressure ranges that define the danger zone (normal ~8–13 cm H₂O; high-risk rises beyond ~17–24 cm H₂O) 
• Long-term outcomes: why some dogs improve clinically even if bile acids stay high (MVD or collateral formation) — treat the patient, not the number

Key takeaway: Surgery ends. Physiology begins.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we continue Tobias Chapter 96 — Hepatic Vascular Anomalies by confronting the shunt-surgery nightmare:

The vessel closed… and the patient crashed.

That crash happens when you treat attenuation like ligation—like you’re just tying off a tube—when it’s actually a high-stakes pressure experiment. Shunt surgery isn’t “closing a hole.” It’s controlled portal hypertension to force portal blood back through a liver that may be too small and too underdeveloped to tolerate the load. 

You’ll learn:

• Why shunt surgery is pressure redistribution, not “vessel removal” 
• The river-dam mental model: abrupt closure floods the system; gradual closure lets the “riverbed” (liver) deepen via hypertrophy 
• Why the portal system is uniquely dangerous: it’s valveless, so pressure transmits upstream instantly 
• What acute portal hypertension looks like in real time: cyanotic gut, mesenteric congestion, “drum-tight” abdomen, and systemic hypotension from blood pooling in the intestines
• The golden rule: temporary occlusion testing is mandatory (measure, don’t guess) 
• The numbers that guide decisions: portal pressure targets and why most dogs require partial attenuation 
• Why device choice is secondary to physiology: ameroid vs cellophane vs hydraulic occluder = different ways to buy time for hypertrophy 
• The first 72-hour threats: hypoglycemia and post-ligation seizures (why the danger isn’t over when you close the skin) 

Key takeaway: attenuation is a negotiation with portal pressure—ignore the pressure, and the portal system is unforgiving.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we continue Tobias Chapter 96 — Hepatic Vascular Anomalies by dismantling the most dangerous mistake clinicians make the moment they see a “bag of worms” on ultrasound:

You found the shunts… but that’s not the disease.

This is a physics episode, not an anatomy episode: the real pathology is portal hypertension — increased intrahepatic resistance in a valveless system. When pressure rises high enough, the body reopens dormant collateral vessels to protect the splanchnic circulation. That chaotic cluster is the pop-off valve, not the defect. 

You’ll learn:

• Why is portal hypertension is the disease, and acquired shunts are the adaptation 
• Why the valveless portal system makes back-pressure immediate and dangerous 
• How to tell congenital vs acquired on imaging: single clean vessel vs chaotic multi-vessel “bag of worms.” 
• The board pearl: multiple portosystemic collaterals + ascites = portal hypertension until proven otherwise
• The fatal mistake: ligating acquired shunts causes acute portal hypertension → blue/purple gut → shock → death 
• What to do instead: treat the pressure and underlying liver disease—manage ascites with spironolactone + low sodium, and treat encephalopathy with lactulose + antibiotics

If you take one line from this episode:
 Treat the cause (resistance), not the compensation (shunts).

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we continue Tobias Chapter 96 — Hepatic Vascular Anomalies by confronting the biggest trap in shunt management:

Same diagnosis ≠  same danger.

A tiny Yorkie and a massive Irish Wolfhound can present with the same story — failure to thrive, post-prandial neuro signs, sky-high bile acids, microhepatica — and still be two completely different surgical problems. 

This episode locks in the governing rule for congenital portosystemic shunts:

Location determines risk. Architecture is destiny.

You’ll learn:

• What a CPSS is physiologically: a portal-to-systemic “routing error” that bypasses hepatic filtration 
• The critical binary: extrahepatic shunts (small breeds, accessible) vs intrahepatic shunts (large breeds, buried in parenchyma) 
• Why are intrahepatic shunts often a patent ductus venosus (fetal bypass that never closed) 
• Why “just ligate it” can kill: hypoplastic liver + tiny portal vasculature → acute portal hypertension when flow is suddenly redirected 
• The modern strategy match:
  • Extrahepatic → gradual attenuation (ameroid constrictor) 
  • Intrahepatic → interventional approach (stent + coils) to avoid deep liver dissection 
• The safety step you don’t skip: temporary occlusion testing + portal pressure limits (watch the manometer and the gut color) 
• The do-not-touch rule: acquired shunts = pop-off valves (“bag of worms” on imaging) — ligate them and you kill the patient 

This episode teaches the decision lens that prevents catastrophe:

don’t pick a technique first. Read the map first.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music

In this BoardsCast episode, we begin Tobias Chapter 96 — Hepatic Vascular Anomalies by reframing portosystemic shunts the way the boards want you to think:

This isn’t a “bad liver” problem, it’s a routing problem — a supply-chain failure where blood skips the liver’s filtration system. 

That’s why these patients can look neurologically catastrophic while the liver looks structurally “fine.” The factory still works — the delivery trucks just drive right past it. 

You’ll learn:

• Normal portal physiology: GI blood must pass through hepatic sinusoids, and the portal vein supplies ~75–80% of hepatic blood flow (and ~half the oxygen) 
• Why shunting causes hepatic encephalopathy: ammonia plus multiple toxins (including “endogenous benzos” acting on GABA receptors) 
• The other half of the disease: the liver starves (loss of trophic factors → hepatic hypoplasia / microhepatica) 
• Board-friendly lab patterns: low BUN, low albumin, low cholesterol, hypoglycemia, and microcytosis
• The do-not-kill-the-patient distinction: congenital shunt (fixable) vs acquired shunts (pressure escape valves—do NOT ligate)
• Clinical triggers + clues: post-prandial worsening (not always), ammonium biurate “thorny apples,” and the feline “copper iris” clue 
• Why the fix is gradual attenuation (ameroid constrictor or cellophane banding) — because the liver has to grow back into the job 

This episode gives you the anchor phrase for Chapter 96:

Ask where the blood went — and what it missed.

🎁 Simini Bonus

Claim your free sample of Simini Protect Lavage (just cover shipping):
https://www.simini.com/getstarted1620808454519

Listen On: Spotify | Apple Podcasts | Amazon Music